Print Page   |   Contact Us   |   Sign In
Community Search
This section will be used for adverts.
Pharmaceutical Companies can advertise here.
Adverts will be rated and run on monthly basis.
it will be first come first served basis

Available at the PSGH secretariat
  • British National Formulary 
    Book by Royal Pharmaceutical Society of Great Britain and British Medical Association
  • The British National Formulary is a pharmaceutical reference book that contains a wide spectrum of information and advice on prescribing and pharmacology, along with specific facts and details about medicines.
  • PSGH CLOTH and other materials
  • Available at the PSGH Secretariat

  • News & Press: Pharmacy Council

    Pharmacy Council moves to regulate hospital pharmacies

    Tuesday, 5 December 2017   (0 Comments)
    Posted by: Frank KUMI, Editor
    Share |

    In a memo sent to all Regional Managers and Heads of Departments of the Pharmacy Council Registrar, the regulatory body has finally decided to regulate and license hospital pharmacies in both public and private sector health institutions.

    This decision follows years of inaction to ensure adherence to standards guiding the practice of pharmacy in clinics and hospitals although the regulatory body has a clear legal mandate to enforce such standards in these practice settings. Until this announcement, the pharmacy regulator has over the years overly focused its resources and energy on community and wholesale pharmacies operated by corporate bodies and individuals.

    In the memo, the Pharmacy Council invoked its mandate derived from section 93 of the Health Professions Regulatory Bodies Act, 2013, Act 857 which partly reads as follows:

    “The [Pharmacy Council] Board may grant a license to a body corporate or a government institution if satisfied that the applicant” can own and operate a pharmacy under the supervision of a registered pharmacist licensed by the body.

    Stakeholders have welcomed this decision of the pharmacy regulatory as a laudable move which promises to safeguard public safety in all areas of pharmaceutical service provision. However, it is unclear at the moment how the regulator intends implementing it.